Skip to main content
Erschienen in: Advances in Gerontology 1/2019

01.01.2019

The Influence of Metformin on Age-Related Changes in the Number and Proliferation of Dermal Fibroblasts in Mice

verfasst von: A. G. Gunin, N. N. Golubtsova, N. O. Subbotkina, A. S. Subbotkin

Erschienen in: Advances in Gerontology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

The goal of the work was to examine the effects of metformin on age-related changes in the number and proliferation of dermal fibroblasts in mice. The dermis was examined in 5-month-old mice that received drinking water with metformin at a concentration of 500 mg/L from the age of 2 months (within 90 days). Five-month-old mice that received drinking water without metformin were used as a control. Material from 2-month-old mice was also used in the work. We have counted the total number of dermal fibroblasts and a portion of fibroblasts with positive staining for the Ki-67 antigen. The results showed that there was a decrease in the total number of mouse dermal fibroblasts by 42.3% from two up to 5 months of life and in the proportion of fibroblasts with positive staining for Ki-67 by 12%. The total number of dermal fibroblasts in 5-month-old mice was 13.4% lower under the effect of metformin. The proportion of fibroblasts with positive staining for Ki-67 was reduced by 27.3% as compared to animals that did not receive metformin. Thus, the age-related decrease in dermal fibroblasts of mice is due to the decline in their proliferation activity. Metformin has an inhibitory effect on the proliferation of dermal fibroblasts in mice.
Literatur
1.
Zurück zum Zitat Anisimov, V.N., Antidiabetic biguanide metformin as geroprotector and anticarcinogen, Ozhirenie Metab., 2011, no. 3, pp. 18–24. Anisimov, V.N., Antidiabetic biguanide metformin as geroprotector and anticarcinogen, Ozhirenie Metab., 2011, no. 3, pp. 18–24.
2.
Zurück zum Zitat Anisimov, V.N., Popovich, I.G., Egormin, P.A., et al., Use of antidiabetic biguanides for the prevention and treatment of cancer: the results of preclinical trials, Vopr. Onkol., 2016, vol. 62, no. 2, pp. 234–244.PubMed Anisimov, V.N., Popovich, I.G., Egormin, P.A., et al., Use of antidiabetic biguanides for the prevention and treatment of cancer: the results of preclinical trials, Vopr. Onkol., 2016, vol. 62, no. 2, pp. 234–244.PubMed
3.
Zurück zum Zitat Arkadieva, A.V., Mamonov, A.A., Popovich, I.G., Anisimov, V.N., Mikhelson, V.M., and Spivak, I.M., Metformin slows down ageing processes at the cellular level in SHR mice, Cell Tissue Biol., 2011, vol. 5, no. 2, pp. 151–159.CrossRef Arkadieva, A.V., Mamonov, A.A., Popovich, I.G., Anisimov, V.N., Mikhelson, V.M., and Spivak, I.M., Metformin slows down ageing processes at the cellular level in SHR mice, Cell Tissue Biol., 2011, vol. 5, no. 2, pp. 151–159.CrossRef
4.
Zurück zum Zitat Gritsenko, D.A., Orlova, O.A., Linkova, N.S., and Khavinson, V.Kh., Transcription factor p53 and skin aging, Adv. Gerontol., 2017, vol. 7, no. 2, pp. 114–119.CrossRef Gritsenko, D.A., Orlova, O.A., Linkova, N.S., and Khavinson, V.Kh., Transcription factor p53 and skin aging, Adv. Gerontol., 2017, vol. 7, no. 2, pp. 114–119.CrossRef
5.
Zurück zum Zitat Chetina, E.V., Nutrient signaling pathways and rheumatic diseases, Nauchno-Prakt. Revmatol., 2013, vol. 51, no. 3, pp. 313–323. Chetina, E.V., Nutrient signaling pathways and rheumatic diseases, Nauchno-Prakt. Revmatol., 2013, vol. 51, no. 3, pp. 313–323.
6.
Zurück zum Zitat Al-Wahab, Z., Mert, I., Tebbe, C., et al., Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction, Oncotarget, 2015, vol. 6, no. 13, pp. 10 908–21 093.CrossRef Al-Wahab, Z., Mert, I., Tebbe, C., et al., Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction, Oncotarget, 2015, vol. 6, no. 13, pp. 10 908–21 093.CrossRef
7.
Zurück zum Zitat Gunin, A.G., Petrov, V.V., Golubtzova, N.N., et al., Age-related changes in angiogenesis in human dermis, Exp. Gerontol., 2014, vol. 55, pp. 143–151.CrossRefPubMed Gunin, A.G., Petrov, V.V., Golubtzova, N.N., et al., Age-related changes in angiogenesis in human dermis, Exp. Gerontol., 2014, vol. 55, pp. 143–151.CrossRefPubMed
8.
Zurück zum Zitat Liu, Y., Zhang, Y., Jia, K., et al., Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway, Exp. Ther. Med., 2015, vol. 9, no. 4, pp. 1401–1406.CrossRefPubMedPubMedCentral Liu, Y., Zhang, Y., Jia, K., et al., Metformin inhibits the proliferation of A431 cells by modulating the PI3K/Akt signaling pathway, Exp. Ther. Med., 2015, vol. 9, no. 4, pp. 1401–1406.CrossRefPubMedPubMedCentral
9.
10.
Zurück zum Zitat Shaw, R.J., Bardeesy, N., Manning, B.D., et al., The LKB1 tumor suppressor negatively regulates mTOR signaling, Cancer Cell, 2004, vol. 6, pp. 91–99.CrossRefPubMed Shaw, R.J., Bardeesy, N., Manning, B.D., et al., The LKB1 tumor suppressor negatively regulates mTOR signaling, Cancer Cell, 2004, vol. 6, pp. 91–99.CrossRefPubMed
11.
Zurück zum Zitat Tomic, T., Botton, T., Cerezo, M., et al., Metformin inhibits melanoma development through autophagy and apoptosis mechanisms, Cell Death Dis., 2011, vol. 2, p. e199.CrossRefPubMedPubMedCentral Tomic, T., Botton, T., Cerezo, M., et al., Metformin inhibits melanoma development through autophagy and apoptosis mechanisms, Cell Death Dis., 2011, vol. 2, p. e199.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Viollet, B., Guigas, B., Garcia, N.S., et al., Cellular and molecular mechanisms of metformin: an overview, Clin. Sci., 2012, vol. 122, pp. 253–270.CrossRefPubMedPubMedCentral Viollet, B., Guigas, B., Garcia, N.S., et al., Cellular and molecular mechanisms of metformin: an overview, Clin. Sci., 2012, vol. 122, pp. 253–270.CrossRefPubMedPubMedCentral
Metadaten
Titel
The Influence of Metformin on Age-Related Changes in the Number and Proliferation of Dermal Fibroblasts in Mice
verfasst von
A. G. Gunin
N. N. Golubtsova
N. O. Subbotkina
A. S. Subbotkin
Publikationsdatum
01.01.2019
Verlag
Pleiades Publishing
Erschienen in
Advances in Gerontology / Ausgabe 1/2019
Print ISSN: 2079-0570
Elektronische ISSN: 2079-0589
DOI
https://doi.org/10.1134/S2079057019010077

Weitere Artikel der Ausgabe 1/2019

Advances in Gerontology 1/2019 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 49 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Chronische Verstopfung: „Versuchen Sie es mit grünen Kiwis!“

22.05.2024 Obstipation Nachrichten

Bei chronischer Verstopfung wirken Kiwis offenbar besser als Flohsamenschalen. Das zeigen die Daten aus einer randomisierten Studie, die der Gastroenterologe Oliver Pech beim Praxis-Update vorstellte.

So häufig greift rheumatoide Arthritis auf Organe über

21.05.2024 Rheumatoide Arthritis Nachrichten

Im Verlauf von rheumatoider Arthritis entwickeln viele Patienten extraartikuläre Manifestationen. Schwedische Forscher haben sich mit der Inzidenz und den Risikofaktoren befasst.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.